Search

Your search keyword '"Bhanot, Nitin"' showing total 318 results
Start Over Author "Bhanot, Nitin"
318 results on '"Bhanot, Nitin"'

2. Inclusion, Diversity, Access, and Equity in Infectious Diseases Fellowship Training: Tools for Program Directors.

Author

Luther, Vera P, Barsoumian, Alice E, Konold, Victoria JL, Vijayan, Tara, Balba, Gayle, Benson, Constance, Blackburn, Brian, Cariello, Paloma, Perloff, Sarah, Razonable, Raymund, Acharya, Kartikey, Azar, Marwan M, Bhanot, Nitin, Blyth, Dana, Butt, Saira, Casanas, Beata, Chow, Brian, Cleveland, Kerry, Cutrell, James B, Doshi, Saumil, Finkel, Diana, Graber, Christopher J, Hazra, Aniruddha, Hochberg, Natasha S, James, Scott H, Kaltsas, Anna, Kodiyanplakkal, Rosy Priya L, Lee, Mikyung, Marcos, Luis, Mena Lora, Alfredo J, Moore, Christopher C, Nnedu, Obinna, Osorio, Georgina, Paras, Molly L, Reece, Rebecca, Salas, Natalie Mariam, Sanasi-Bhola, Kamla, Schultz, Sara, Serpa, Jose A, Shnekendorf, Rachel, Weisenberg, Scott, Wooten, Darcy, Zuckerman, Richard A, Melia, Michael, and Chirch, Lisa M

Subjects
diversity, equity, inclusion, infectious diseases fellowship, medical education, Good Health and Well Being
Abstract

The Infectious Diseases Society of America (IDSA) has set clear priorities in recent years to promote inclusion, diversity, access, and equity (IDA&E) in infectious disease (ID) clinical practice, medical education, and research. The IDSA IDA&E Task Force was launched in 2018 to ensure implementation of these principles. The IDSA Training Program Directors Committee met in 2021 and discussed IDA&E best practices as they pertain to the education of ID fellows. Committee members sought to develop specific goals and strategies related to recruitment, clinical training, didactics, and faculty development. This article represents a presentation of ideas brought forth at the meeting in those spheres and is meant to serve as a reference document for ID training program directors seeking guidance in this area.

Published
2023

7. Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia

Author

Walsh, Thomas L., Bremmer, Derek N., Moffa, Matthew A., Trienski, Tamara L., Buchanan, Carley, Stefano, Kelly, Hand, Catharine, Taylor, Tricia, Kasarda, Karen, Shively, Nathan R., Bhanot, Nitin, Cheronis, Nicholas, DiSilvio, Briana E., Cho, Christian Y., and Carr, Dustin R.

Published
2021
Full Text
View/download PDF

12. Correction to: Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia

Author

Walsh, Thomas L., Bremmer, Derek N., Moffa, Matthew A., Trienski, Tamara L., Buchanan, Carley, Stefano, Kelly, Hand, Catharine, Taylor, Tricia, Kasarda, Karen, Shively, Nathan R., Bhanot, Nitin, Cheronis, Nicholas, DiSilvio, Briana E., Cho, Christian Y., and Carr, Dustin R.

Published
2021
Full Text
View/download PDF

14. Implementing and validating a home-infusion central-line–associated bloodstream infection surveillance definition

Author

Keller, Sara C., Hannum, Susan M., Weems, Kimberly, Oladapo-Shittu, Opeyemi, Salinas, Alejandra B., Marsteller, Jill A., Gurses, Ayse P., Klein, Eili Y., Shpitser, Ilya, Crnich, Christopher J., Bhanot, Nitin, Rock, Clare, and Cosgrove, Sara E.

Abstract

AbstractObjective:Central-line–associated bloodstream infection (CLABSI) surveillance in home infusion therapy is necessary to track efforts to reduce infections, but a standardized, validated, and feasible definition is lacking. We tested the validity of a home-infusion CLABSI surveillance definition and the feasibility and acceptability of its implementation.Design:Mixed-methods study including validation of CLABSI cases and semistructured interviews with staff applying these approaches.Setting:This study was conducted in 5 large home-infusion agencies in a CLABSI prevention collaborative across 14 states and the District of Columbia.Participants:Staff performing home-infusion CLABSI surveillance.Methods:From May 2021 to May 2022, agencies implemented a home-infusion CLABSI surveillance definition, using 3 approaches to secondary bloodstream infections (BSIs): National Healthcare Safety Program (NHSN) criteria, modified NHSN criteria (only applying the 4 most common NHSN-defined secondary BSIs), and all home-infusion–onset bacteremia (HiOB). Data on all positive blood cultures were sent to an infection preventionist for validation. Surveillance staff underwent semistructured interviews focused on their perceptions of the definition 1 and 3–4 months after implementation.Results:Interrater reliability scores overall ranged from κ = 0.65 for the modified NHSN criteria to κ = 0.68 for the NHSN criteria to κ = 0.72 for the HiOB criteria. For the NHSN criteria, the agency-determined rate was 0.21 per 1,000 central-line (CL) days, and the validator-determined rate was 0.20 per 1,000 CL days. Overall, implementing a standardized definition was thought to be a positive change that would be generalizable and feasible though time-consuming and labor intensive.Conclusions:The home-infusion CLABSI surveillance definition was valid and feasible to implement.

Published
2023
Full Text
View/download PDF

15. A case of fever in a returning traveler.

Author

Wrynn, Alexander and Bhanot, Nitin

Subjects
*MALARIA prevention, *TREATMENT of fever, *MALARIA diagnosis, *DIAGNOSIS of fever, *FEVER, *HOSPITAL emergency services, *NOMADS, *COVID-19, *AIR travel, *MALARIA, *ANTIMALARIALS, *FATIGUE (Physiology), *HEADACHE, *BLOOD cell count, *COVID-19 testing
Abstract

After the lifting of COVID-19 restrictions, international travel has demonstrated recovery to prepandemic levels. Travel, particularly to tropical regions, can be associated with contracting various infectious diseases. For this reason, collecting a travel history is a necessity when assessing any patient with vague infectious symptoms, most notably fever. Early suspicion, identification, and treatment of tropical illnesses can be lifesaving. This case study concerns a patient who recently traveled to Africa and is under evaluation for fever in the emergency department. The proper approach to the febrile traveler and the pathophysiology, diagnosis, and treatment of malaria are reviewed. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

20. Utility of Direct Specimen Sequencing in Addition to Conventional Testing in Management of Infections in an Urban Referral Health Center.

Author

Saini, Vikram, Como, James, Abdulmassih, Rasha, Min, Zaw, and Bhanot, Nitin

Subjects
URBAN health, MEDICAL centers, TURNAROUND time, COMMUNICABLE diseases, DIAGNOSIS
Abstract

Background: Direct specimen sequencing (DSS) offers the promise of enhanced pathogen detection and disease diagnosis. Methods: A single healthcare network, retrospective chart review over a 3-year period was completed for all cases in which DSS was submitted, in addition to conventional testing (CT) for workup of an infectious disease. We sought to compare results (concordance and discordance) from these 2 techniques in order to evaluate any additional yield from DSS over CT. Additionally, we calculated mean turnaround time (TAT) and average cost for obtaining DSS on all specimens. Results: A total of 23 patients' specimens were sent for DSS. DSS and CT concordance occurred in 91% (21/23) of cases. DSS testing was able to identify specific pathogens in 17.4% (4/23) of patients, out of which 4% (1/23) were discordant. The respective mean TAT and total cost per specimen for DSS were 6 days and $821.52 (range $573–$1590), respectively. Conclusions: In our limited cohort of patients, there was significant concordance between the 2 testing modalities primarily due to negative tests. DSS did not provide significant additional yield in the infectious diagnosis in our cohort compared to CT. Short TAT may provide advantage in the detection of fastidious organisms, but high cost remains a limitation. Larger sample size may reveal a clinically meaningful difference. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

21. A Bicyclist’s Tale

Author

Min, Zaw, primary, Alvarez, Gabriela, additional, Rao, Sheldon, additional, Khoury, Fadi, additional, Cheema, Tariq, additional, Bhanot, Nitin, additional, Bishop, Henry S, additional, Qvarnstrom, Yvonne, additional, Sapp, Sarah G H, additional, and Cantey, Paul T, additional

Published
2022
Full Text
View/download PDF

42. COVID-19

Author

Ogbebor, Osakpolor, Min, Zaw, Cheema, Tariq, and Bhanot, Nitin

Subjects
Critical Care
Published
2020
Full Text
View/download PDF

43. A Great Masquerader: Nasal Type, Extranodal Natural Killer/T-cell Lymphoma Presenting as Recalcitrant Bacterial Sinusitis and Periorbital Cellulitis

Author

Min, Zaw and Bhanot, Nitin

Subjects
Article Subject, otorhinolaryngologic diseases
Abstract

Nasal extranodal natural killer/T-cell lymphoma (ENKL) is a rare clinical entity. It may, however, masquerade as a commonly encountered disease, such as sinusitis. A high index of clinical suspicion of nasal ENKL should be raised when there is inadequate clinical response despite appropriate therapeutic intervention of sinusitis. Biopsy would be warranted and crucial in those instances to make an accurate and timely diagnosis.

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results